Back
PT Telkom Indonesia (Persero) Tbk Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
31
TLK
PT Telkom Indonesia (Persero) Tbk
Last Price:
$21.08
Seasonality Move:
2.03%
Buy
57
LYEL
Lyell Immunopharma, Inc.
Last Price:
$36.08
Seasonality Move:
-22.7%
Sell
31
PT Telkom Indonesia (Persero) Tbk (TLK)
is a Sell
Is PT Telkom Indonesia (Persero) Tbk a Buy, Sell or Hold?
-
The current PT Telkom Indonesia (Persero) Tbk [TLK] share price is $21.11. The Score for TLK is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
TLK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $36.05. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TLK Stock Price Chart
What is PT Telkom Indonesia (Persero) Tbk's stock price today?
-
The PT Telkom Indonesia (Persero) Tbk share price today is $21.11Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TLK is experiencing slight buying pressure.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $36.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight buying pressure.
TLK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.85 | Buy |
| Relative Strength Index (14 RSI): | 48.9 | Sell |
| Chaikin Money Flow: | 176334 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.06 - 21.9) | Sell |
| Bollinger Bands (100): | (18.85 - 21.19) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.11 | Buy |
| Relative Strength Index (14 RSI): | 67.85 | Buy |
| Chaikin Money Flow: | 30003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.49 - 35.13) | Buy |
| Bollinger Bands (100): | (10.87 - 25.69) | Buy |
TLK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.05 | Buy |
| 20-day SMA: | 21.41 | Sell |
| 50-day SMA: | 20.88 | Buy |
| 200-day SMA: | 18.08 | Buy |
| 8-day EMA: | 18.25 | Buy |
| 20-day EMA: | 11.6 | Buy |
| 50-day EMA: | 5.76 | Buy |
| 200-day EMA: | 1.62 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.28 | Buy |
| 20-day SMA: | 31 | Buy |
| 50-day SMA: | 23.25 | Buy |
| 200-day SMA: | 13.99 | Buy |
| 8-day EMA: | 35.25 | Buy |
| 20-day EMA: | 31.52 | Buy |
| 50-day EMA: | 25.41 | Buy |
| 200-day EMA: | 18.18 | Buy |
PT Telkom Indonesia (Persero) Tbk Earnings Growth & TLK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.19 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
PT Telkom Indonesia (Persero) Tbk Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||